首页 | 本学科首页   官方微博 | 高级检索  
检索        

29例原发系统性间变大细胞淋巴瘤的病理特点及临床分析
引用本文:陈焱,何群,舒义刚,李晓林.29例原发系统性间变大细胞淋巴瘤的病理特点及临床分析[J].临床血液学杂志,2009,22(2).
作者姓名:陈焱  何群  舒义刚  李晓林
作者单位:中南大学湘雅医院血液科,长沙,410008  
摘    要:目的:探讨原发系统性间变大细胞淋巴瘤(ALCL)的病理特点、临床特征与预后的关系.方法:对29例原发系统性ALCL患者的病理特点、临床特征、完全缓解率(CR)、长期生存率和预后因素进行了分析.结果:所有病例的瘤细胞均强表达CD30,58.62%间变性淋巴瘤激酶(ALK)阳性.接受了治疗的28例患者的CR率为50.0%,2年和5年生存率分别为51.3%与27.1%.ALK阳性患者CR为68.8%,2、5年无病生存率分别为60.2%、42.5%,明显高于ALK阴性组(P<0.05).国际预后指数(IPI)0~2分患者组CR率为57.1%,2年、5年无病生存率分别为80.2%、65.1%,明显高于IP13~5分患者组(P<0.05).Cox比例风险回归分析表明ALK的表达、IPI评分对预后的影响有统计学意义(P<0.05).结论:ALK表达、IPI评分有助于判断原发系统性ALCL的预后,并为个体化治疗提供了依据.

关 键 词:淋巴瘤  间变大细胞  国际预后指数  间变性淋巴瘤激酶

The clinical and pathological analysis for 29 cases with systemic anaplastic large cell lymphoma
CHEN Yan HE Qun SHU Yigang LI Xiaolin.The clinical and pathological analysis for 29 cases with systemic anaplastic large cell lymphoma[J].Journal of Clinical Hematology,2009,22(2).
Authors:CHEN Yan HE Qun SHU Yigang LI Xiaolin
Institution:Department of Hematology;Xiangya Hospital;Centre-South University;Changsha;410008;China
Abstract:Objective:To study the correlation of clinical prognosis with pathological and clinical features in patients with systemic anaplastic large cell lymphoma (ALCL). Method:Twenty-nine patients diagnosed with systemic ALCL were analyzed by the clinical and pathological features, complete remission (CR), long-term survival rate, and prognostic factors. Result:All patients were CD30 positive. Positive rate of anaplastic lymphoma kinase (ALK) was 58.62%. The CR of 28 patients was 50.0%, and overall survival (OS) r...
Keywords:lymphoma  anaplastic large cell  international prognostic index  anaplastic lymphoma kinase  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号